A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Virology

• Publication date

  2015-12-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02723-15PMID 26676793PMCID PMC4810719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

  2015cited by this paper
• Structure of influenza A polymerase bound to the viral RNA promoter

  2014cited by this paper
• Development of a Mouse-Adapted Live Attenuated Influenza Virus That Permits In Vivo Analysis of Enhancements to the Safety of Live Attenuated Influenza Virus Vaccine

  2014cited by this paper
• The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing

  2012cited by this paper
• Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

  2012cited by this paper
• Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)

  2011cited by this paper
• Benefits and risks of live attenuated influenza vaccine in young children.

  2010cited by this paper
• The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

  2010cited by this paper
• Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age

  2010cited by this paper
• The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination

  2010cited by this paper
• Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production.

  2009cited by this paper
• Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

  2008cited by this paper
• Live attenuated versus inactivated influenza vaccine in infants and young children.

  2007cited by this paper
• Regulation of the Interferon System : Evidence that Vero Cells have a Genetic Defect in Interferon Production

  2007cited by this paper
• Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.

  2003cited by this paper
• Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.

  1999cited by this paper
• Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

  1998cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

  1996cited by this paper
• Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

  1979cited by this paper
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

  year unknowncited by this paper

• PB1 mutations as key drivers of influenza A virus evolution

  2026cites this paper
• Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.

  2023cites this paper
• A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccine

  2022cites this paper
• Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine

  2022cites this paper
• Could live attenuated vaccines better control COVID-19?

  2021cites this paper
• Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

  2021cites this paper
• A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity

  2020influential citation
• Исследование отдельных звеньев иммунной системы мышей, иммунизированных сайт-специфическими мутантами вируса гриппа

  2020cites this paper
• Inclusion of site-specific mutations in the PB1-gene of a virulent A/WSN/33 (H1N1) strain of influenza A virus changes its phenotypic characteristics

  2019cites this paper
• Включение сайт-специфических мутаций в РВ1-ген вирулентного штамма A/WSN/33 (H1N1) вируса гриппа А меняет его фенотипические характеристики

  2019cites this paper
• Study of the biological properties of attenuated variants of the virulent A/WSN/33 strain of influenza virus, obtained by the site-specific mutagenesis of PB2-gene

  2019cites this paper
• Influenza Vaccine With Consensus Internal Antigens as Immunogens Provides Cross-Group Protection Against Influenza A Viruses

  2019cites this paper
• A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus

  2019cites this paper
• A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus

  2019cites this paper
• Creation of live influenza vaccines with the use of site-specific mutagenesis

  2017cites this paper